Table 3.

The patients’ self-reported symptoms at the time of study inclusion

	S/PCR+	S/PCR−	p-Value
Cough, %	100 (19/19)a	71.5 (89/125)a	0.004
Fever, anamnestic, %	73.7 (14/19)a	60.8 (76/125)a	0.321
Phlegm, %	52.9 (9/17)a	50.4 (59/117)a	1.000
Nasal discharge, %	52.6 (10/19)a	31.2 (39/125)a	0.075
Sore throat, %	42.1 (8/19)a	21.6 (27/125)a	0.081
No. of symptomatic days, mean (SD)	5.8 (3.8)	5.7 (5.3)	0.940

Persistent, self-reported symptoms at the time of study inclusion, lasting less than 3 weeks. A comparison between the two groups was performed by the use of Fisher’s exact two-sided test, with significant p-values at < 0.05

^aNumber of patients reporting symptoms/total number of patients